WHO ICTRP trial

A 24-week randomized, single blinded study in subjects with Chronic Obstructive…

EUCTR2017-001593-42-NL · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2017-001593-42-NL
Public title A 24-week randomized, single blinded study in subjects with Chronic Obstructive Pulmonary Disease (COPD) to evaluate the effect of reminders and motivational/adaptive messages on treatment adherence tracked by the Concept2 inhaler
Scientific title A 24-week randomized, multicenter, single blinded, international study to evaluate the effect of reminder notifications and motivational/adaptive messaging on treatment adherence of COPD subjects receiving Ultibro® Breezhaler® treatment using the Concept2 inhaler for dose tracking
Primary sponsor Novartis Pharma AG
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries Czech Republic;Belgium;Ireland;Austria;Germany;Netherlands;United Kingdom
Conditions Chronic Obstructive Pulmonary Disease (COPD) MedDRA version: 20.0 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000004855 ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Interventions Trade Name: Ultibro Breezhaler Product Name: indacaterol maleate/glycopyrronium Product Code: QVA149 Pharmaceutical Form: Inhalation powder, hard capsule INN or Proposed INN: indacaterol maleate CAS Number: 753498-25-8 Other descriptive…
Registration date Apr 30, 2018
Target size 146
Secondary IDs CIDD001D2402;2017-001593-42-AT
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations